XBiotech (XBIT) Short Interest Ratio & Short Volume → [FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (From Crypto 101 Media) (Ad) Free XBIT Stock Alerts $8.43 -0.15 (-1.75%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media XBiotech Short Interest DataCurrent Short Volume709,900 sharesPrevious Short Volume670,600 sharesChange Vs. Previous Month+5.86%Dollar Volume Sold Short$5.44 millionShort Interest Ratio / Days to Cover9.1Last Record DateApril 30, 2024Outstanding Shares30,460,000 sharesFloat Size18,320,000 sharesShort Percent of Float3.88%Today's Trading Volume29,994 sharesAverage Trading Volume62,262 sharesToday's Volume Vs. Average48% Short Selling XBiotech ? Sign up to receive the latest short interest report for XBiotech and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatXBIT Short Interest Over TimeXBIT Days to Cover Over TimeXBIT Percentage of Float Shorted Over Time Ad Porter & CompanyObama’s Forever Term [exposed]America’s Last Election New documentary, America’s Last Election, reveals the true (and terrifying) story of how the D.C. establishment has engineered a brutal new crisis that could hand them permanent power. Power they will use to reshape America to their dark, dystopian vision.Start streaming it now at no cost here XBiotech Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024709,900 shares $5.44 million +5.9%3.9%9.1 $7.67 4/15/2024670,600 shares $6.31 million +10.9%3.4%9.4 $9.41 3/31/2024604,500 shares $4.91 million +3.3%3.1%10 $8.13 3/15/2024585,300 shares $3.46 million +8.9%3.0%12.8 $5.91 2/29/2024537,500 shares $3.36 million +35.4%2.7%14.6 $6.26 2/15/2024397,000 shares $2.29 million +5.4%2.0%12.1 $5.78 Get the Latest News and Ratings for XBIT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for XBiotech and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024376,500 shares $1.73 million +9.6%1.9%15.5 $4.59 1/15/2024343,500 shares $1.72 million +1.2%1.7%16.8 $5.00 12/31/2023339,400 shares $1.36 million -0.6%1.7%18.9 $4.00 12/15/2023341,500 shares $1.59 million -0.2%1.7%19 $4.65 11/30/2023342,300 shares $1.34 million +9.5%1.8%21.1 $3.92 11/15/2023312,500 shares $1.19 million +6.1%1.7%17.2 $3.80 10/31/2023294,500 shares $1.23 million -1.3%1.6%16.5 $4.18 10/15/2023298,500 shares $1.17 million +7.7%1.6%17.5 $3.93 9/30/2023277,200 shares $1.14 million +9.0%1.5%15.5 $4.12 9/15/2023254,400 shares $1.16 million +72.4%1.4%11.9 $4.55 8/31/2023147,600 shares $726,192.00 -11.9%0.8%5 $4.92 8/15/2023167,600 shares $812,860.00 +9.9%0.9%3.5 $4.85 7/31/2023152,500 shares $767,075.00 -5.8%0.8%1.8 $5.03 7/15/2023161,900 shares $841,880.00 -0.6%0.9%1.8 $5.20 6/30/2023162,800 shares $967,032.00 +4.6%0.9%1.8 $5.94 6/15/2023155,600 shares $955,384.00 +79.1%0.8%1.7 $6.14 5/31/202386,900 shares $442,755.50 +3.7%0.5%1.1 $5.10 5/15/202383,800 shares $279,892.00 +23.1%0.5%1.2 $3.34 4/30/202368,100 shares $234,264.00 -5.0%0.4%2.3 $3.44 4/15/202371,700 shares $255,252.00 -10.0%0.4%2.4 $3.56 3/31/202379,700 shares $274,965.00 +12.7%0.5%2.5 $3.45 3/15/202370,700 shares $238,966.00 -15.0%0.4%2 $3.38 2/28/202383,200 shares $279,552.00 +22.5%0.5%2.1 $3.36 2/15/202367,900 shares $249,193.00 -6.1%0.4%1.7 $3.67 1/31/202372,300 shares $314,505.00 -9.7%0.4%1.9 $4.35 1/15/202380,100 shares $373,266.00 +0.8%0.5%2.1 $4.66 12/30/202279,500 shares $279,045.00 -22.1%0.5%2.1 $3.51 12/15/2022102,000 shares $332,520.00 -27.2%0.6%2.8 $3.26 11/30/2022140,100 shares $453,924.00 +16.9%0.9%3.9 $3.24 11/15/2022119,800 shares $433,676.00 +24.7%0.8%3 $3.62 10/31/202296,100 shares $337,311.00 +42.4%0.6%2.2 $3.51 10/15/202267,500 shares $247,050.00 -11.0%0.4%1.4 $3.66 9/30/202275,800 shares $274,396.00 +9.9%0.5%1.6 $3.62 9/15/202269,000 shares $280,830.00 -22.2%0.4%0.8 $4.07Elon’s New Device is About to Shock the World (Ad)Using this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake. XBIT Short Interest - Frequently Asked Questions What is XBiotech's current short interest? Short interest is the volume of XBiotech shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 709,900 shares of XBIT short. 3.88% of XBiotech's shares are currently sold short. Learn More on XBiotech's current short interest. What is a good short interest ratio for XBiotech? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. XBIT shares currently have a short interest ratio of 9.0. Learn More on XBiotech's short interest ratio. What is a good short interest percentage for XBiotech? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.88% of XBiotech's floating shares are currently sold short. Is XBiotech's short interest increasing or decreasing? XBiotech saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 709,900 shares, an increase of 5.9% from the previous total of 670,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is XBiotech's float size? XBiotech currently has issued a total of 30,460,000 shares. Some of XBiotech's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. XBiotech currently has a public float of 18,320,000 shares. How does XBiotech's short interest compare to its competitors? 3.88% of XBiotech's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to XBiotech: Emergent BioSolutions Inc. (14.13%), ESSA Pharma Inc. (2.09%), MacroGenics, Inc. (17.02%), Akebia Therapeutics, Inc. (5.66%), Immutep Limited (3.06%), Xeris Biopharma Holdings, Inc. (6.50%), Enanta Pharmaceuticals, Inc. (14.15%), Design Therapeutics, Inc. (9.06%), Inozyme Pharma, Inc. (8.23%), Neoleukin Therapeutics, Inc. (0.35%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short XBiotech stock? Short selling XBIT is an investing strategy that aims to generate trading profit from XBiotech as its price is falling. XBIT shares are trading down $0.15 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against XBiotech? A short squeeze for XBiotech occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of XBIT, which in turn drives the price of the stock up even further. How often is XBiotech's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including XBIT, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Emergent BioSolutions Short Interest Data ESSA Pharma Short Interest Data MacroGenics Short Interest Data Akebia Therapeutics Short Interest Data Immutep Short Interest Data Xeris Biopharma Short Interest Data Enanta Pharmaceuticals Short Interest Data Design Therapeutics Short Interest Data Inozyme Pharma Short Interest Data Neoleukin Therapeutics Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:XBIT) was last updated on 5/18/2024 by MarketBeat.com Staff From Our Partners[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders AllianceThe Presidential candidate you should REALLY be worried aboutStansberry ResearchProtect Your Bank Account Before It’s Too LateWeiss RatingsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressWhat’s Really Next for America…Porter & CompanyHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlace